These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 10189278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.
    Wong SL, Cao G, Mack RJ, Granneman GR.
    Clin Pharmacol Ther; 1997 Aug; 62(2):157-64. PubMed ID: 9284851
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function.
    Wong SL, Menacherry S, Mulford D, Schmitz PJ, Locke C, Granneman GR.
    Eur J Clin Pharmacol; 1997 Aug; 52(3):223-7. PubMed ID: 9218930
    [Abstract] [Full Text] [Related]

  • 9. Myocardium distribution of sertindole and its metabolite dehydrosertindole in guinea-pigs.
    Canal-Raffin M, Titier K, Déridet E, Martinez B, Abouelfath A, Miras A, Gromb S, Molimard M, Moore N.
    Biopharm Drug Dispos; 2006 May; 27(4):171-9. PubMed ID: 16419145
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients.
    Cantillon M, Ings R, Bhat L.
    Clin Transl Sci; 2018 Jul; 11(4):378-386. PubMed ID: 29119704
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of sertindole and its metabolite dehydrosertindole in rats and characterization of their comparative pharmacodynamics based on in vivo D2 receptor occupancy and behavioural conditioned avoidance response.
    Bundgaard C, Larsen F, Kreilgaard M, Brennum LT, Olsen CK.
    Biopharm Drug Dispos; 2009 May; 30(4):209-20. PubMed ID: 19475539
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A, Sesoko S, Nakashima M, Hayashi N, Taniguchi A, Horie Y, Graefe-Mody EU, Woerle HJ, Dugi KA.
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model.
    Hard ML, Mills RJ, Sadler BM, Wehr AY, Weiden PJ, von Moltke L.
    CNS Drugs; 2017 Jul; 31(7):617-624. PubMed ID: 28597226
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study.
    Morain P, Robin JL, De Nanteuil G, Jochemsen R, Heidet V, Guez D.
    Br J Clin Pharmacol; 2000 Oct; 50(4):350-9. PubMed ID: 11012558
    [Abstract] [Full Text] [Related]

  • 18. Isomazole disposition in man as a function of dose and route of administration.
    Woodworth JR, Delong AF, Fasola AF, Oldham S.
    Biopharm Drug Dispos; 1991 Dec; 12(9):673-86. PubMed ID: 1790312
    [Abstract] [Full Text] [Related]

  • 19. Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers.
    Huang SM, Marriott TB, Weintraub HS, Arnold JD, Boccagno J, Abels R, Harris W.
    Eur J Clin Pharmacol; 1988 Dec; 34(1):101-4. PubMed ID: 2896125
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and pharmacodynamic studies following single and multiple doses of rolafagrel, a novel inhibitor of thromboxane synthase, in normal volunteers.
    Gatti G, Bartoli A, Bertin D, Strolin-Benedetti M, Perucca E.
    Eur J Clin Pharmacol; 1994 Dec; 47(3):275-80. PubMed ID: 7867681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.